Baker Botts, Latham Tapped For $932M Innophos Sale

Law360 (October 21, 2019, 2:46 PM EDT) -- Specialty ingredients producer Innophos said Monday it plans to sell itself to private equity firm One Rock Capital for about $932 million, in a deal guided by Baker Botts and Latham & Watkins.

New Jersey-based Innophos, which develops ingredients used in the health and nutrition, food and beverage and industrial markets, said the sale comes as the result of a strategic review. 

According to Innophos Chairman, President and CEO Kim Ann Mink, the deal is the best bet for the company’s shareholders.

“We remain confident that our transformational strategy is the right path forward for Innophos; however, executing on this strategy...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!